脓毒症患者新发心房颤动的研究现状及进展
Research Status and Progress of New Atrial Fibrillation in Patients with Sepsis
DOI: 10.12677/acm.2025.151162, PDF,   
作者: 杜海娜, 单泓达：承德医学院研究生学院，河北 承德；刘宇鹏*：秦皇岛市第一医院急诊科，河北 秦皇岛
关键词: 脓毒症；心房颤动；卒中；抗凝治疗；Sepsis； Atrial Fibrillation； Stroke； Anticoagulant Therapy
摘要: 心房颤动是脓毒症患者病程中最常见的新发心律失常，脓毒症患者并发心房颤动时治疗更复杂，预后更差，不仅延长住院时间，还会增加患者卒中和死亡的风险。本综述旨在总结分析当前关于脓毒症相关新发心房颤动的研究状况与最新进展，探讨脓毒症患者新发心房颤动的生理机制、风险因素、抗凝治疗及临床结局，以期更全面地理解如何预防心房颤动对脓毒症患者造成的不良影响，并寻求更好的临床治疗决策。
Abstract: Atrial fibrillation is the most common new-onset arrhythmia in patients with sepsis, and patients with sepsis complicated by atrial fibrillation are more complicated to treat, have a worse prognosis, prolong hospital stays, and increase the risk of stroke and death. The purpose of this review is to summarize and analyze the current research status and latest progress on sepsis-related new-onset atrial fibrillation, and to explore the physiological mechanism, risk factors, anticoagulation therapy and clinical outcomes of new-onset atrial fibrillation in patients with sepsis, in order to understand more comprehensively how to prevent the adverse effects of atrial fibrillation on patients with sepsis, and to seek better clinical treatment decisions.
文章引用：杜海娜, 刘宇鹏, 单泓达. 脓毒症患者新发心房颤动的研究现状及进展[J]. 临床医学进展, 2025, 15(1): 1226-1231. https://doi.org/10.12677/acm.2025.151162

参考文献

[1] Evans, L., Rhodes, A., Alhazzani, W., et al. (2021) Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Medicine, 47, 1181-1247.
[2] Fang, J., Kong, B., Shuai, W., Xiao, Z., Dai, C., Qin, T., et al. (2021) Ferroportin-Mediated Ferroptosis Involved in New-Onset Atrial Fibrillation with LPS-Induced Endotoxemia. European Journal of Pharmacology, 913, Article ID: 174622. [Google Scholar] [CrossRef] [PubMed]
[3] Chu, C., Yang, C., Wang, X., Xie, T., Sun, S., Liu, B., et al. (2020) Early Intravenous Administration of Tranexamic Acid Ameliorates Intestinal Barrier Injury Induced by Neutrophil Extracellular Traps in a Rat Model of Trauma/Hemorrhagic Shock. Surgery, 167, 340-351. [Google Scholar] [CrossRef] [PubMed]
[4] Xiang, J., Cao, J., Wang, X., Shao, S., Huang, J., Zhang, L., et al. (2024) Neutrophil Extracellular Traps and Neutrophil Extracellular Traps-Related Genes Are Involved in New-Onset Atrial Fibrillation in LPS-Induced Sepsis. International Immunopharmacology, 138, Article ID: 112550. [Google Scholar] [CrossRef] [PubMed]
[5] Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analysis for the Global Burden of Disease Study. The Lancet, 395, 200-211. [Google Scholar] [CrossRef] [PubMed]
[6] Xiao, F., Chen, M., Wang, L., He, H., Jia, Z., Kuai, L., et al. (2021) Outcomes of New-Onset Atrial Fibrillation in Patients with Sepsis: A Systematic Review and Meta-Analysis of 225,841 Patients. The American Journal of Emergency Medicine, 42, 23-30. [Google Scholar] [CrossRef] [PubMed]
[7] Kuipers, S., Klouwenberg, P.M.K. and Cremer, O.L. (2014) Incidence, Risk Factors and Outcomes of New-Onset Atrial Fibrillation in Patients with Sepsis: A Systematic Review. Critical Care, 18, Article No. 688. [Google Scholar] [CrossRef] [PubMed]
[8] Huang, M., Cai, S. and Su, J. (2019) The Pathogenesis of Sepsis and Potential Therapeutic Targets. International Journal of Molecular Sciences, 20, Article No. 5376. [Google Scholar] [CrossRef] [PubMed]
[9] Corica, B., Romiti, G.F., Basili, S. and Proietti, M. (2022) Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine, 12, Article No. 547. [Google Scholar] [CrossRef] [PubMed]
[10] Meierhenrich, R., Steinhilber, E., Eggermann, C., Weiss, M., Voglic, S., Bögelein, D., et al. (2010) Incidence and Prognostic Impact of New-Onset Atrial Fibrillation in Patients with Septic Shock: A Prospective Observational Study. Critical Care, 14, R108. [Google Scholar] [CrossRef] [PubMed]
[11] Klein Klouwenberg, P.M.C., Frencken, J.F., Kuipers, S., Ong, D.S.Y., Peelen, L.M., van Vught, L.A., et al. (2017) Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with Sepsis. A Cohort Study. American Journal of Respiratory and Critical Care Medicine, 195, 205-211. [Google Scholar] [CrossRef] [PubMed]
[12] Yao, C., Veleva, T., Scott, L., Cao, S., Li, L., Chen, G., et al. (2018) Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation, 138, 2227-2242. [Google Scholar] [CrossRef] [PubMed]
[13] Sagris, M., Vardas, E.P., Theofilis, P., Antonopoulos, A.S., Oikonomou, E. and Tousoulis, D. (2021) Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. International Journal of Molecular Sciences, 23, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[14] 唐念中, 刘芬. 脓毒症休克快速心律失常研究进展[J]. 海军军医大学学报, 2023, 44(11): 1328-1336.
[15] Downes, M., Welters, I.D. and Johnston, B.W. (2023) Study Protocol: A Systematic Review and Meta-Analysis Regarding the Influence of Coagulopathy and Immune Activation on New Onset Atrial Fibrillation in Patients with Sepsis. PLOS ONE, 18, e0290963. [Google Scholar] [CrossRef] [PubMed]
[16] Bosch, N.A., Cimini, J. and Walkey, A.J. (2018) Atrial Fibrillation in the ICU. Chest, 154, 1424-1434. [Google Scholar] [CrossRef] [PubMed]
[17] Li, Z., Pang, M., Li, Y., Yu, Y., Peng, T., Hu, Z., et al. (2022) Development and Validation of a Predictive Model for New-Onset Atrial Fibrillation in Sepsis Based on Clinical Risk Factors. Frontiers in Cardiovascular Medicine, 9, Article ID: 968615. [Google Scholar] [CrossRef] [PubMed]
[18] Arunachalam, K., Kalyan Sundaram, A., Jha, K., Thakur, L. and Pond, K. (2020) Evaluation of Anticoagulation Practice with New-Onset Atrial Fibrillation in Patients with Sepsis and Septic Shock in Medical Intensive Care Unit: A Retrospective Observational Cohort Study. Cureus, 12, e10026. [Google Scholar] [CrossRef] [PubMed]
[19] Leng, Y., Li, Y., Wang, J., Deng, P., Wang, W., Wu, J., et al. (2023) Sepsis as an Independent Risk Factor in Atrial Fibrillation and Cardioembolic Stroke. Frontiers in Endocrinology, 14, Article ID: 1056274. [Google Scholar] [CrossRef] [PubMed]
[20] Wu, Y., Kong, X., Ji, Y., Fan, J., Ji, C., Chen, X., et al. (2024) Serum Electrolyte Concentrations and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study. BMC Genomics, 25, Article No. 280. [Google Scholar] [CrossRef] [PubMed]
[21] Schwartz, A., Brotfain, E., Koyfman, L., Kutz, R., Gruenbaum, S.E., Klein, M., et al. (2014) Association between Hypophosphatemia and Cardiac Arrhythmias in the Early Stage of Sepsis: Could Phosphorus Replacement Treatment Reduce the Incidence of Arrhythmias? Electrolytes & Blood Pressure, 12, 19-25. [Google Scholar] [CrossRef] [PubMed]
[22] 罗文治, 高敏, 刘晶晶, 等. 脓毒症患者新发房颤的相关危险因素分析[J]. 实用休克杂志(中英文), 2020, 4(3): 151-154.
[23] Liu, Y., Wang, Y., Chen, Y., Dong, R., Li, S., Peng, J., et al. (2024) A Nationwide Study on New Onset Atrial Fibrillation Risk Factors and Its Association with Hospital Mortality in Sepsis Patients. Scientific Reports, 14, Article No. 12206. [Google Scholar] [CrossRef] [PubMed]
[24] Schwartz, A., Brotfain, E., Koyfman, L. and Klein, M. (2015) Cardiac Arrhythmias in a Septic ICU Population: A Review. The Journal of Critical Care Medicine, 1, 140-146. [Google Scholar] [CrossRef] [PubMed]
[25] Walkey, A.J., Greiner, M.A., Heckbert, S.R., Jensen, P.N., Piccini, J.P., Sinner, M.F., et al. (2013) Atrial Fibrillation among Medicare Beneficiaries Hospitalized with Sepsis: Incidence and Risk Factors. American Heart Journal, 165, 949-955.e3. [Google Scholar] [CrossRef] [PubMed]
[26] 袁新, 阿布力克木·阿布拉, 程浩东, 等. 脓毒症新发心律失常的影响因素分析[J]. 实用心脑肺血管病杂志, 2021, 29(3): 63-67.
[27] Myers, L.C., Peltan, I.D., Thai, K.K., Kipnis, P., Desai, M., Devis, Y., et al. (2024) Predicting Stroke Risk after Sepsis Hospitalization with New‐Onset Atrial Fibrillation. Journal of Hospital Medicine, 19, 565-571. [Google Scholar] [CrossRef] [PubMed]
[28] Walkey, A.J., Myers, L.C., Thai, K.K., Kipnis, P., Desai, M., Go, A.S., et al. (2023) Practice Patterns and Outcomes Associated with Anticoagulation Use Following Sepsis Hospitalizations with New-Onset Atrial Fibrillation. Circulation: Cardiovascular Quality and Outcomes, 16, e009494. [Google Scholar] [CrossRef] [PubMed]
[29] Quon, M.J., Behlouli, H. and Pilote, L. (2018) Anticoagulant Use and Risk of Ischemic Stroke and Bleeding in Patients with Secondary Atrial Fibrillation Associated with Acute Coronary Syndromes, Acute Pulmonary Disease, or Sepsis. JACC: Clinical Electrophysiology, 4, 386-393. [Google Scholar] [CrossRef] [PubMed]
[30] Darwish, O.S., Strube, S., Nguyen, H.M. and Tanios, M.A. (2013) Challenges of Anticoagulation for Atrial Fibrillation in Patients with Severe Sepsis. Annals of Pharmacotherapy, 47, 1266-1271. [Google Scholar] [CrossRef] [PubMed]

为你推荐